Emily Slotkin (@EmilySlotkin) header
Emily Slotkin (@EmilySlotkin) profile picture

Emily Slotkin

@EmilySlotkin

MSK Kids, Pediatric Sarcoma Service | DSRCT, Ewing and other AYA sarcomas | Memorial Sloan Kettering Cancer Center

Joined June 2009
  • Tweets42
  • Following483
  • Followers331
4Media
Photo by Emily Slotkin (@EmilySlotkin)Photo by Emily Slotkin (@EmilySlotkin)Photo by Emily Slotkin (@EmilySlotkin)Photo by Emily Slotkin (@EmilySlotkin)
Here we provide an update on high risk Wilms tumors as a part of the @COGorg and @WorldSIOP pediatric renal tumor collaborative #HARMONICA initiative - pubmed.ncbi.nlm.nih.gov/3662…
Advances in the clinical management of high-risk Wilms tumors - PubMed

Advances in the clinical management of high-risk Wilms tumors - PubMed

Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival rate is approximately 50% or lower. Acknowledging that the...

pubmed.ncbi.nlm.nih.gov
5
16
1,549
Robust translational partnerships are essential to rapidly advance novel therapies for #childhoodcancer; herein @HeathcliffDora1 @anton_gh find ATRi as a novel approach to treat #ARMS which directly informed the actively recruiting @COGorg study PEPN2112 clinicaltrials.gov/ct2/show/…
Anton Henssen (@anton_gh) profile pictureAnton Henssen@anton_gh26 Jul 2022
Very happy to share this new publication from our lab, led by @HeathcliffDora1 , where we describe that preclinical models of alveolar rhabdomysarcoma are exceptionally sensitive to pharmacological ATR inhibition 🔥🔥👇🏻👇🏻 @NatureComms #1 rdcu.be/cSml9
1
3
11
Emily Slotkin retweeted
Emily Slotkin (@EmilySlotkin) profile picture
Emily Slotkin@EmilySlotkin9 Nov 2022
Replying to @WCMEnglanderIPM @MSKCancerCenter @WCMC_CTSC
Thank you @WCMC_CTSC!
1
1
🔬TODAY "How Osteosarcoma Evolves from Diagnosis to Relapse" - @MDKinnz of @MSKCancerCenter is joining us on OsteoBites to talk about this evolution. 👉You can join us LIVE today, Thursday at 3pm EDT: us02web.zoom.us/webinar/regi… ✨This episode is sponsored by @osinstitute (OSI)
Image from MIB Agents Osteosarcoma Alliance (@AgentsMIB)
2
2
1
Emily Slotkin retweeted
The Lancet (@TheLancet) profile picture
The Lancet
@TheLancet4 Nov 2022
"An intercontinental divide for the upfront treatment of Ewing sarcoma has persisted... The EE2012 results harmonise treatment approaches." @EmilySlotkin & @WTapMD provide a linked Comment: hubs.li/Q01rlKVd0
2
1
2
📢The 10th Paediatric Strategy Forum for DNA Damage Repair Pathway Inhibitors has now begun at @EMA_News! ➡️Stay tuned for the summary and manuscript addressing the challenges and documenting the conclusions of the meeting. #ChildhoodCancer #DrugDevelopment #ACCELERATEcure
Image from ACCELERATE (@ACCELERATE_cure)
2
4
4
Emily Slotkin retweeted
MSK Library (@MSKLibrary) profile picture
MSK Library
@MSKLibrary12 Oct 2022
Featured today by @MSKLibrary: Leveraging Circulating Tumor DNA to Optimize the Initial Management of Childhood #RenalTumors @MichaelVOrtiz @JCO_ASCO dx.doi.org/10.1200/JCO.22.00…
Leveraging Circulating Tumor DNA to Optimize the Initial Management of Childhood Renal Tumors

Leveraging Circulating Tumor DNA to Optimize the Initial Management of Childhood Renal Tumors

ascopubs.org
2
1
Emily Slotkin retweeted
Anton Henssen (@anton_gh) profile picture
Anton Henssen@anton_gh26 Jul 2022
Very happy to share this new publication from our lab, led by @HeathcliffDora1 , where we describe that preclinical models of alveolar rhabdomysarcoma are exceptionally sensitive to pharmacological ATR inhibition 🔥🔥👇🏻👇🏻 @NatureComms #1 rdcu.be/cSml9
4
14
1
56
Had a blast this morning sharing a snapshot of my work studying clonal evolution in osteosarcoma! Work made possible by the support of many generous foundations including @ConquerCancerFd @hopeonwheels @quadwfoundation @RallyFoundation. Hoping to share the full story soon!#ASCO22
Image from Michael Kinnaman, MD MS (@MDKinnz)
5
6
2
32
Many thanks to all collaborators for their work on and attention to #DSRCT! @MLadanyi @ahmetz @PapaemmanuilLab @WTapMD @MCR_AACR @sloan_kettering
Molecular Cancer Research (@MCR_AACR) profile pictureMolecular Cancer Research@MCR_AACR2 Jul 2021
Desmoplastic Small Round Cell Tumor is defined by a simple and balanced translocation and characterized by a paucity of recurrent mutations. FGFR4 overexpression may represent a therapeutic vulnerability. bit.ly/2V3JFAD #DSRCT
Image from Molecular Cancer Research (@MCR_AACR)
2
6
33
👏most fun…👏birthday present…👏ever! thank you mom, mattie and @dglaucomflecken 🤩 cameo.com/v/60bba08bec038100…
4
Emily Slotkin retweeted
NY Genome Center (@nygenome) profile picture
NY Genome Center@nygenome11 Mar 2021
Join us for the VIRTUAL Very Rare Cancer Consortium Disease Spotlight & Research Roundtable on #DSCRT, 3/18, 4pm – 6pm. Speakers from @sloan_kettering (including @EmilySlotkin, @MLadanyi, @oleg8r, & @906Madelyn) plus @columbia & @MDAndersonNews. Details: bit.ly/3vkmkZh
Image from NY Genome Center (@nygenome)
8
17
It would mean a great deal to me if everyone I know, & everyone you know would RT this post about our genomics cancer projects. Anyone dx'd with a brain tumor or osteosarcoma in the US & Canada can join here: BrainCancerProject.org & OSproject.org #BTSM #Sarcoma TY!
6
148
9
96
congratulations to @MLadanyi @lee_spraggon and all others on this paper! clinical trial based on these data evaluating TPX-005 with irinotecan/temozolomide in relapsed/refractory DSRCT will be open in ~2 months @sloan_kettering led by the amazing Dr. Tara O’Donohue #DSRCT
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
2
14
Intraperitoneal radioimmunotherapy with 131I-omburtamab (anti-B7H3 murine monoclonal antibody) for patients with desmoplastic small round cell tumor was well tolerated and feasible fal.cn/3bpqh @EmilySlotkin @sloan_kettering #scmsm #JCO
Image from Journal of Clinical Oncology (@JCO_ASCO)
4
5
Very excited to share the results of this #DSRCT trial! ascopubs.org/doi/abs/10.1200… The phase 2 version of this study is now open and accruing: clinicaltrials.gov/ct2/show/… @sloan_kettering
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic...

B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic...

PURPOSEDesmoplastic small round cell tumor (DSRCT), a rare sarcoma of adolescents/young adults primarily involving the peritoneum, has a long-term survival of < 20% despite aggressive multimodality...

ascopubs.org
2
5
2
24
congratulations to @DrDNFriedman as well for moderating the afternoon session! thank you @WTapMD @JGladeBender, Dr. Lindsay Frazier, Dr. Ann LaCasce for giving us this chance to think about #AYAcancer @sloan_kettering @DanaFarber #MSKkids
Danielle Friedman MD (@DrDNFriedman) profile pictureDanielle Friedman MD@DrDNFriedman31 Jan 2020
Inspirational talk about bridging the gap in clinical trial development for DSRCT and RMS patients at the MSK-DFCI AYA Oncology Research Symposium by ⁦@EmilySlotkin⁩ #mskkids
Image from Danielle Friedman MD (@DrDNFriedman)
1
16
in Seattle at @Cycle4Survival to express our gratitude to those who have joined the battle - thank you for supporting our rare cancer research efforts! @sloan_kettering @Equinox #cycleforsurvival #MSKKids
Image from Emily Slotkin (@EmilySlotkin)
Image from Emily Slotkin (@EmilySlotkin)
1
1
19
Holiday cheer with my pediatric sarcoma and renal/liver tumor family! I am so lucky to be surrounded by these lovely people. @MichaelVOrtiz @MDKinnz @JGladeBender @sloan_kettering #MSKkids
Image from Emily Slotkin (@EmilySlotkin)
1
22
Load more